{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:03:53Z","timestamp":1780113833068,"version":"3.54.0"},"reference-count":18,"publisher":"Tottori University Faculty of Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Yonago Acta Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.33160\/yam.2026.05.008","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:09:35Z","timestamp":1779401375000},"page":"218-222","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Myelin Oligodendrocyte Glycoprotein Antibody\u2013Positive Aseptic Meningitis at the Identical Site in a Child: Leptomeningeal Enhancement Detected by Contrast-Enhanced FLAIR Imaging"],"prefix":"10.33160","volume":"69","author":[{"given":"Ayano","family":"Okuda","sequence":"first","affiliation":[{"name":"Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Okanishi","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Ohta","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"},{"name":"Division of Epileptology, Comprehensive Epilepsy Center, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikko","family":"Ohshiro","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"},{"name":"Division of Pediatrics, Gifu Municipal Hospital, Gifu 500-8323, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Arai","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"},{"name":"Department of Epileptology (Krankenhaus Mara), Bethel Epilepsy Center, Medical School, Bielefeld University, Bielefeld 33617, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Kanai","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"},{"name":"Division of Pediatric Neurology, David Geffen School of Medicine, University of California, Los Angeles 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Maegaki","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18656","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria. Lancet Neurol. 2023;22:268-82. PMID:36706773, DOI:10.1016\/S1474-4422(22)00431-8","DOI":"10.1016\/S1474-4422(22)00431-8"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, et al.; BIOMARKER Study Group. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 2017;89:900-8. PMID:28768844, DOI:10.1212\/WNL.0000000000004312","DOI":"10.1212\/WNL.0000000000004312"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, et al. Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody\u2013associated disease. JAMA Neurol. 2018;75:478-87. PMID:29305608, DOI:10.1001\/jamaneurol.2017.4601","DOI":"10.1001\/jamaneurol.2017.4601"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140:3128-38. PMID:29136091, DOI:10.1093\/brain\/awx276","DOI":"10.1093\/brain\/awx276"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Narayan RN, Wang C, Sguigna P, Husari K, Greenberg B. Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. Mult Scler Relat Disord. 2019;27:30-3. PMID:30300850, DOI:10.1016\/j.msard.2018.10.003","DOI":"10.1016\/j.msard.2018.10.003"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Li L, Liu W, Cai Q, Liu Y, Hu W, Zuo Z, et al. Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images. Front Immunol. 2023;14:1152235. PMID:37409120, DOI:10.3389\/fimmu.2023.1152235","DOI":"10.3389\/fimmu.2023.1152235"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Gombolay GY, Gadde JA. Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review. J Neuroimmunol. 2021;358:577653. PMID:34229204, DOI:10.1016\/j.jneuroim.2021.577653","DOI":"10.1016\/j.jneuroim.2021.577653"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, et al. Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2017;4:e343. PMID:28451627, DOI:10.1212\/NXI.0000000000000343","DOI":"10.1212\/NXI.0000000000000343"},{"key":"9","unstructured":"9. Griffiths PD, Coley SC, Romanowski CA, Hodgson T, Wilkinson ID. Contrast-enhanced fluid-attenuated inversion recovery imaging for leptomeningeal disease in children. AJNR Am J Neuroradiol. 2003;24:719-23. PMID:12695212"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Ahmad A, Azad S, Azad R. Differentiation of leptomeningeal and vascular enhancement on post-contrast FLAIR MRI Sequence: Role in Early Detection of Infectious Meningitis. J Clin Diagn Res. 2015;9:TC08-12. PMID:25738054, DOI:10.7860\/JCDR\/2015\/11519.5387","DOI":"10.7860\/JCDR\/2015\/11519.5387"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Fukuoka H, Hirai T, Okuda T, Shigematsu Y, Sasao A, Kimura E, et al. Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T. AJNR Am J Neuroradiol. 2010;31:868-73. PMID:20037130, DOI:10.3174\/ajnr.A1937","DOI":"10.3174\/ajnr.A1937"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Ahn SJ, Taoka T, Moon WJ, Naganawa S. Contrast\u2010Enhanced Fluid\u2010Attenuated Inversion Recovery in Neuroimaging: A Narrative Review on Clinical Applications and Technical Advances. J Magn Reson Imaging. 2022;56:341-53. PMID:35170148, DOI:10.1002\/jmri.28117","DOI":"10.1002\/jmri.28117"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Lin S, Long W, Wen J, Su Q, Liao J, Hu Z. Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype. Mult Scler Relat Disord. 2022;68:104126. PMID:36115288, DOI:10.1016\/j.msard.2022.104126","DOI":"10.1016\/j.msard.2022.104126"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Bruijstens AL, Wendel EM, Lechner C, Bartels F, Finke C, Breu M, et al. E.U. paediatric MOG consortium consensus: Part 5 \u2013 Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020;29:41-53. PMID:33176999, DOI:10.1016\/j.ejpn.2020.10.005","DOI":"10.1016\/j.ejpn.2020.10.005"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al.; Australasian and New Zealand MOG Study Group. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89:127-37. PMID:29142145, DOI:10.1136\/jnnp-2017-316880","DOI":"10.1136\/jnnp-2017-316880"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Trewin BP, Dale RC, Qiu J, Chu M, Jeyakumar N, Dela Cruz F, et al.; Australasian MOGAD Study Group. Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse. J Neurol Neurosurg Psychiatry. 2024;95:1054-63. PMID:38744459, DOI:10.1136\/jnnp-2024-333463","DOI":"10.1136\/jnnp-2024-333463"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Budhram A, Mirian A, Flanagan EP. Unilateral cortical fluid-attenuated inversion recovery-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein-associated encephalitis with seizures (FLAMES): an under-recognized entity. Pediatr Neurol. 2020;110:99-100. PMID:32682599, DOI:10.1016\/j.pediatrneurol.2020.05.003","DOI":"10.1016\/j.pediatrneurol.2020.05.003"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023;14:1137998. PMID:36925938, DOI:10.3389\/fneur.2023.1137998","DOI":"10.3389\/fneur.2023.1137998"}],"container-title":["Yonago Acta Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/69\/2\/69_2026.05.008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:23:45Z","timestamp":1780111425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/69\/2\/69_2026.05.008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.33160\/yam.2026.05.008","relation":{},"ISSN":["1346-8049"],"issn-type":[{"value":"1346-8049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026.05.008"}}